首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1824166

全球精準醫療市場：2025-2030年未來預測

Global Precision Medicine Market - Forecasts from 2025 to 2030

出版日期: 2025年08月24日 | 出版商:

Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

精準醫療市場規模

精準醫療市場預計將從 2025 年的 1,092.97 億美元成長到 2030 年的 1,865.06 億美元，複合年成長率為 11.28%。

精準醫療市場：分析概述

市場概況

精準醫療，又稱個人化醫療，是指醫師根據對個別病患基因的了解來選擇治療方案的醫療方法。市場發展的主要驅動力是慢性疾病（包括心血管疾病、肥胖及其相關疾病）的日益普及。隨著醫療保健系統尋求更有針對性和更有效的治療性介入，這種個人化治療方法正日益受到青睞。

全球慢性病負擔的增加是市場成長的主要驅動力。心血管疾病是全球主要死亡原因之一，約佔全球死亡人數的31%。大多數心血管相關死亡是由中風和心臟病發作引起的，因此對能夠提供更有針對性的預防和治療策略的精準醫療方法的需求巨大。

應用於慢性疾病

認知障礙和阿茲海默症

阿茲海默症及其相關的認知障礙是精準醫療技術的重要應用領域。目前的預測顯示，受此影響的人數將顯著增加，預計到2050年，美國阿茲海默症人數將達到約1,400萬人。這一人口趨勢正在推動針對認知障礙的精準醫療解決方案的持續市場需求。

研究和開發正在揭示治療有效性的重要見解。布法羅大學的科學家發現，75% 的美國人體內都存在一個人類基因，這可能是導致一種治療阿茲海默症的藥物在動物模型中顯示出良好效果，但在人體研究中卻失敗的原因。這項發現凸顯了精準醫療方法相對於傳統治療方法的重要性，並預示了基於基因的治療策略的市場潛力。

糖尿病治療中的應用

糖尿病是精準醫療市場成長的另一個大驅動力。美國國家糖尿病、消化和腎臟疾病研究所已將精準醫療列為其糖尿病基因組學和遺傳學計畫的重點，該計畫旨在識別能夠預防第1型和第2型糖尿病的基因間區域和基因。

醫療保健機構正在實施精準醫療技術來治療糖尿病，並且取得了令人欣喜的成果。麻省總醫院的一項研究表明，以個人基因圖譜和數據為重點的干涉措施成功降低了第二型糖尿病的風險，證明了精準醫療方法在糖尿病管理中的有效性。

數位健康整合

衛生系統正在透過數位健康計畫拓展其精準醫療能力。路易斯安那州衛生系統（Ochsner Health）為患者提供全面的數位健康解決方案，並大力投資開發直接面對消費者的遠端醫療服務和交付系統。未來10年，該組織計畫將遠端醫療服務擴展到重症監護室（ICU）、精神科和中風護理領域，展現精準醫療與數位醫療交付的融合。

癌症治療應用

癌症治療是精準醫療市場擴張的主要驅動力。癌症是全球第二大死因，每年約有960萬人死亡。約70%的癌症死亡發生在中低收入國家，凸顯了精準醫療解決方案在全球市場的巨大機會。

由於癌症發展過程中基因會不斷變化，精準醫療方法尤其適用於癌症治療。科學家正在努力開發並實施基因檢測，以確定針對每個癌症病例和腫瘤的最佳治療方法。這種個人化方法解決了癌症病理的異質性，並透過標靶治療選擇來改善治療效果。

研發機構正在開發綜合資料庫，以加速精準醫療療法的開發。多個機構正在合作建立頭頸癌資料庫，以加速精準醫療治療方法的開發和生產。這些資料庫正在揭示關鍵的癌症相關蛋白質和基因，加深我們對癌症路徑的理解。

技術進步和夥伴關係

精準醫療市場透過策略夥伴關係和技術創新不斷發展。基因序列測定是精準醫療發展的基礎，產業合作致力於提升完整的基因組分析能力。這些夥伴關係正在推動多個治療領域創新精準醫療解決方案的發展。

市場展望

精準醫療市場展現出強勁的成長潛力，這得益於慢性病盛行率的不斷上升、技術進步以及醫療體系對個人化治療方法的採用。對基因的理解及其與臨床照護的結合，為針對各種疾病狀態的更有效、更有針對性的治療性介入創造了機會。

本報告的主要優點

深刻分析：獲得深入的市場洞察，重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場，涵蓋主要地區和新興地區。
競爭格局：了解主要企業所採用的策略策略，並了解正確策略的市場滲透潛力。
市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力來制定策略決策，在動態環境中開闢新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業來說，既有利又划算。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024）和預測資料（2025-2030）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按部門和地區（國家）分類的收益成長和預測分析
公司概況（策略、產品、財務資訊、主要趨勢等）

Precision medicine, also known as personalized medicine, represents a medical approach where doctors select treatments based on genetic understanding of individual patients. The market is primarily driven by the increasing prevalence of chronic diseases including cardiovascular diseases, obesity, and related conditions. This personalized approach to treatment has gained significant traction as healthcare systems seek more targeted and effective therapeutic interventions.

The market growth is substantially influenced by the global burden of chronic diseases. Cardiovascular diseases represent one of the major causes of death worldwide, accounting for approximately 31% of global deaths. Most cardiovascular-related deaths result from strokes and heart attacks, creating substantial demand for precision medicine approaches that can provide more targeted prevention and treatment strategies.

Chronic Disease Applications

Cognitive Disorders and Alzheimer's Disease

Alzheimer's disease and related cognitive disorders represent significant applications for precision medicine technology. Current projections indicate substantial growth in affected populations, with estimates suggesting the number of Americans living with Alzheimer's disease could reach approximately 14 million by 2050. This demographic trend drives sustained market demand for precision medicine solutions targeting cognitive disorders.

Research developments have revealed important insights into treatment effectiveness. Scientists at the University of Buffalo discovered that a human gene present in 75% of the American population contributes to why certain Alzheimer's disease medications fail in human studies despite showing promising results in animal studies. This discovery highlights the importance of precision medicine approaches over conventional treatments and demonstrates the market potential for genetically-informed therapeutic strategies.

Diabetes Treatment Applications

Diabetes represents another major driver for precision medicine market growth. The National Institute of Diabetes and Digestive and Kidney Diseases has made precision medicines a major priority for its Diabetes Genomics and Genetics Program. The program aims to identify intergenic regions and genes that provide protection against type 1 and type 2 diabetes.

Medical institutions are implementing precision medicine techniques for diabetes treatment with promising results. Massachusetts General Hospital research demonstrated that interventions focused on individuals' genetic profiles and data successfully reduced type 2 diabetes risk, validating the precision medicine approach for diabetes management.

Digital Health Integration

Healthcare systems are expanding precision medicine capabilities through digital health programs. The Louisiana Health system (Ochsner Health) provides comprehensive digital health solutions to patients and has made substantial investments in developing direct-to-consumer telemedicine care services and delivery systems. The organization plans to expand telehealth services for ICU, psychiatry, and stroke care applications over the next decade, demonstrating the integration of precision medicine with digital healthcare delivery.

Cancer Treatment Applications

Cancer treatment represents a primary driver for precision medicine market expansion. Cancer ranks as the second major cause of death worldwide, with an estimated 9.6 million deaths annually. Approximately 70% of cancer deaths occur in lower and middle-income countries, highlighting global market opportunities for precision medicine solutions.

Cancer treatment applications are particularly suited for precision medicine approaches because genetic changes constantly occur in cancer development. Scientists are working to identify and conduct genetic tests that determine optimal treatment approaches for individual cancer cases and tumors. This personalized approach addresses the heterogeneity of cancer presentations and improves treatment outcomes through targeted therapeutic selection.

Research institutions are developing comprehensive databases to accelerate precision medicine therapy development. Collaborative efforts involving multiple organizations have compiled databases of head and neck cancers to speed development and production of precision medicine therapies. These databases provide clarification of key cancer-associated proteins and genes, resulting in advancement of cancer pathway understanding.

Technological Advancement and Partnerships

The precision medicine market continues evolving through strategic partnerships and technological innovation. Genetic sequencing represents a fundamental component of precision medicine development, with industry collaborations focused on advancing complete genomic profiling capabilities. These partnerships drive development of novel and innovative precision medicine solutions across multiple therapeutic areas.

Market Outlook

The precision medicine market demonstrates strong growth potential driven by chronic disease prevalence, technological advancement, and healthcare system adoption of personalized treatment approaches. The integration of genetic understanding with clinical care creates opportunities for more effective, targeted therapeutic interventions across diverse medical conditions.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global Precision Medicine Market Segments:

By Technology

Data Analytics (including AI/ML)
Bioinformatics
Gene Sequencing
Genomics/Functional Genomics
Proteomics
Metabolomics
Digital Health Technologies
Companion Diagnostics

By Application

Oncology
Central Nervous System
Immunology
Cardiovascular
Rare Diseases
Infectious Diseases
Respiratory Diseases
Metabolic Disorders
Hematology

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL PRECISION MEDICINE MARKET BY TECHNOLOGY

5.1. Introduction
5.2. Data Analytics (including AI/ML)
5.3. Bioinformatics
5.4. Gene Sequencing
5.5. Genomics/Functional Genomics
5.6. Proteomics
5.7. Metabolomics
5.8. Digital Health Technologies
5.9. Companion Diagnostics

6. GLOBAL PRECISION MEDICINE MARKET BY APPLICATION

6.1. Introduction
6.2. Oncology
6.3. Central Nervous System
6.4. Immunology
6.5. Cardiovascular
6.6. Rare Diseases
6.7. Infectious Diseases
6.8. Respiratory Diseases
6.9. Metabolic Disorders
6.10. Hematology

7. GLOBAL PRECISION MEDICINE MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. USA
- 7.2.2. Canada
- 7.2.3. Mexico
7.3. South America
- 7.3.1. Brazil
- 7.3.2. Argentina
- 7.3.3. Others
7.4. Europe
- 7.4.1. Germany
- 7.4.2. France
- 7.4.3. United Kingdom
- 7.4.4. Spain
- 7.4.5. Others
7.5. Middle East and Africa
- 7.5.1. Saudi Arabia
- 7.5.2. UAE
- 7.5.3. Others
7.6. Asia Pacific
- 7.6.1. China
- 7.6.2. India
- 7.6.3. Japan
- 7.6.4. South Korea
- 7.6.5. Indonesia
- 7.6.6. Thailand
- 7.6.7. Others